Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Beyond blood pressure

N R Poulter1

  • 1University College London Medical School, Department of Epidemiology and Public Health, UK.

Journal of Human Hypertension
|September 1, 1994
PubMed
Summary
This summary is machine-generated.

Hypertension management should prioritize preventing coronary heart disease (CHD). Newer medications may offer better protection against CHD by improving related risk factors compared to older drugs.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Reductions in lipids and CV risk markers in patients with type 2 diabetes treated with liraglutide: a meta-analysis.

Canadian journal of diabetes·2015
Same author

The influence of physical activity on vascular complications and mortality in patients with type 2 diabetes mellitus.

Diabetes, obesity & metabolism·2013
Same author

Resting heart rate and the risk of death and cardiovascular complications in patients with type 2 diabetes mellitus.

Diabetologia·2012
Same author

Metabolic syndrome, impaired fasting glucose and obesity, as predictors of incident diabetes in 14 120 hypertensive patients of ASCOT-BPLA: comparison of their relative predictability using a novel approach.

Diabetic medicine : a journal of the British Diabetic Association·2011
Same author

The economic consequences of non-adherence to lipid-lowering therapy: results from the Anglo-Scandinavian-Cardiac Outcomes Trial.

International journal of clinical practice·2010
Same author

Effects of HIV status and antiretroviral therapy on blood pressure.

HIV medicine·2009
Same journal

Patient out-of-pocket costs for antihypertensive single pill combination products with cost caps.

Journal of human hypertension·2026
Same journal

Mindfulness based interventions for blood pressure reduction: systematic and umbrella review of existing meta-analyses.

Journal of human hypertension·2026
Same journal

Invasive observation of reactive systolic blood pressure responses to upper-arm cuff inflation.

Journal of human hypertension·2026
Same journal

Association between post-thrombectomy blood pressure trajectories and clinical outcomes in hypertensive patients with acute ischemic stroke: a retrospective cohort study.

Journal of human hypertension·2026
Same journal

Systemic inflammation indices generated from first-trimester blood tests can be potential biomarkers for predicting preeclampsia.

Journal of human hypertension·2026
Same journal

Chronotherapy in hypertension: a systematic review and meta-analysis of antihypertensive dosing timing on cardiovascular outcomes.

Journal of human hypertension·2026
See all related articles

Area of Science:

  • Cardiology
  • Hypertension Management
  • Preventive Cardiology

Background:

  • Elevated blood pressure is a leading cause of coronary heart disease (CHD) mortality.
  • CHD has a multifactorial etiology, necessitating comprehensive risk factor management.
  • Optimal hypertension treatment requires addressing all co-existing risk factors in patients.

Purpose of the Study:

  • To evaluate the role of newer antihypertensive agents in managing hypertension and preventing CHD.
  • To compare the potential benefits of newer agents (ACE inhibitors, calcium antagonists, alpha-blockers) versus older agents (diuretics, beta-blockers) in CHD prevention.
  • To guide clinical practice in selecting optimal hypertension therapy in the absence of long-term outcome data.

Main Methods:

  • Review of existing data on the effects of antihypertensive agents on cardiovascular risk factors.

Related Experiment Videos

  • Analysis of the impact of newer agents on serum lipids, glucose intolerance, hyperinsulinaemia, and left ventricular hypertrophy.
  • Clinical estimation of optimal therapeutic strategies based on current evidence.

    • Main Results:

    • Newer agents like ACE inhibitors, calcium antagonists, and alpha-blockers show favorable effects on key CHD risk factors.
    • These newer agents are potentially more protective against coronary morbidity and mortality than diuretics and beta-blockers.
    • Long-term morbidity and mortality trial data for newer agents are pending.

    Conclusions:

    • Hypertension management should focus on preventing CHD by addressing all risk factors.
    • Newer antihypertensive medications demonstrate promising effects on cardiovascular risk profiles.
    • Physicians must currently make informed therapeutic decisions based on available evidence regarding newer agents.